Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • California guideCalifornia Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›AN41--Research Services Neural Stem Cell Study for Spinal…

Awarded contract·U.S. Department Of Veterans Affairs·California

AN41--Research Services Neural Stem Cell Study for Spinal Cord Injury

Won by PHARMARON (SAN DIEGO) LAB SERVICES LLC$1.1MAwarded 9/17/2026Single Award
Contract source

Awarded vendors

  • PHARMARON (SAN DIEGO) LAB SERVICES LLC

Description

This contract awards a $1.09 million sole‑source task order to PHARMARON (San Diego) Lab Services LLC for research services focused on a neural stem‑cell study aimed at treating spinal‑cord injury for the VA San Diego Healthcare System. The work will involve in‑vivo safety and efficacy testing of GMP H9‑scNSCs under GLP conditions. The award is administered by the Veterans Health Administration’s Regional Procurement Office East in Pittsburgh, Pennsylvania. • Scope: Pre‑clinical biomedical research, GLP‑compliant in‑vivo safety/efficacy testing of neural stem cells. • Funding: $1,088,660, awarded under FAR 6.302‑1 (sole‑source). • Vendor: PHARMARON (SAN DIEGO) LAB SERVICES LLC, a laboratory services provider located in Carlsbad, CA.

Attached files

Key dates

Bids closed
10/17/2026
Intent to award
9/17/2026
Awarded
9/17/2026
Contract modified
10/17/2026
Starts
9/17/2026

Last updated

Details

Award type
Single Award
Procurement
Sole Source
Industry
Healthcare and Medical Services
NAICS
541380
Solicitation №
36C24E26R0021

Contract value

$1,088,660

The contract value is explicitly stated as $1,088,660.00 in the award details. This amount represents the total ceiling for the task order covering all research services, labor, materials, and any related expenses for the neural stem‑cell study. No additional funding sources (e.g., Recovery Act) are indicated, so the full amount is attributable to the VA’s standard budget.

AI estimate from the award documents

Similar open opportunities

Matched by Bid Banana AI™

Pennsylvania Department of Health·Pennsylvania

Top match · 74%

Spinal Cord Injury Research Grant

Closes 12/10/2026Opened 10/8/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

73% match

DoW Spinal Cord Injury, Clinical Trial Award

Closes 11/12/2026Opened 5/5/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

73% match

DoW Spinal Cord Injury, Clinical Translation Research Award

Closes 11/12/2026Opened 5/5/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

72% match

DoW Spinal Cord Injury, Investigator-Initiated Research Award

Closes 11/12/2026Opened 5/5/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

71% match

DoW Spinal Cord Injury, Translational Research Award

Closes 11/12/2026Opened 5/5/2026

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Closes 6/23/2028Opened 8/28/2025

U.S. National Institutes of Health·United States of America

70% match

National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Closes 1/24/2027Opened 6/9/2026

U.S. National Institutes of Health·United States of America

69% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

69% match

Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/6/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

69% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. Department Of Health And Human Services·District of Columbia

69% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

69% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

University of South Carolina·South Carolina

68% match

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

68% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

68% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. National Institutes of Health·United States of America

68% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. National Institutes of Health·United States of America

68% match

Learning Disabilities Research Centers

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

68% match

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

Closes 9/25/2027Opened 9/24/2024

U.S. National Institutes of Health·United States of America

68% match

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Closes 1/28/2027Opened 2/23/2024

U.S. National Institutes of Health·United States of America

67% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

67% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

67% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026